Spatially encoded biological assays

Patent No. US10662468 (titled "Spatially encoded biological assays") on Oct 22, 2019. The application was issued on May 26, 2020.

What is this patent about?

’468 is related to the field of spatially encoded biological assays and high-resolution molecular mapping. It specifically addresses the challenge of simultaneously measuring the abundance and distribution of numerous biological targets, such as nucleic acids and proteins, within a solid tissue sample while preserving the original spatial context of those molecules.

The underlying idea behind ’468 is the decoupling of target detection from spatial localization through a digital encoding scheme. Instead of relying on physical separation or visual microscopy alone, the invention uses coding tags—unique oligonucleotide sequences—that act as coordinate markers. By linking these location-specific tags to probes that capture biological targets, the system converts spatial information into a digital sequence format that can be processed in bulk.

The claims of ’468 focus on a method for determining the presence or abundance of a nucleic acid at a specific location in a tissue section using an array of capture agents. Each capture agent is a chimeric molecule featuring a sequence that specifically binds a target nucleic acid and a second sequence containing a coding tag that identifies the agent's precise position on the array.

In practice, the tissue section is placed in contact with the array, allowing the capture agents to hybridize with the target molecules in the sample. Once the targets are bound, the combined genetic information—the identity of the target and its corresponding spatial tag—is read out using high-throughput sequencing. This allows the researcher to pool all the data into a single reaction while retaining the ability to computationally map every molecule back to its exact origin in the tissue.

This approach differs from prior methods like laser capture microdissection or standard in situ hybridization by offering massive scalability and a digital readout. By using a combinatorial grid of tags, the system can resolve thousands of different targets across millions of locations simultaneously. This eliminates the labor-intensive physical handling of tissue fragments and provides a quantitative, high-resolution map of cellular function that was previously unattainable.

How does this patent fit in bigger picture?

Technical Landscape

In the early 2010s when ’468 was filed, the analysis of biological molecules in tissue samples was typically implemented using techniques such as in situ hybridization or laser capture microdissection. At a time when systems commonly relied on the physical transference of tissue into discrete wells or the manual isolation of small cell populations to preserve spatial context, hardware and software constraints made the simultaneous measurement of high-plex gene or protein expression across large, contiguous spatial areas non-trivial. Consequently, standard practices often forced a trade-off between achieving high levels of multiplexing and maintaining the high-resolution spatial architecture of the original biological specimen.

Prosecution Position

The disclosed invention represents a meaningful technical advancement through an architectural shift in spatial biology that integrates multiplexed molecular assays with a digital encoding scheme. By delivering encoded probes to a sample in defined spatial patterns—where each probe contains a coding tag identifying its delivery location—the system enables the pooling of assay products for high-throughput sequencing while retaining the ability to map results back to specific coordinates. This integration overcomes the technical constraint of low spatial resolution inherent in physical tissue partitioning, enabling the simultaneous digital quantification of thousands of biological targets across a sample surface without sacrificing the underlying structural context of the tissue.

Claims

This patent contains 30 claims, with claim 1 being the sole independent claim. The independent claim focuses on a method for determining the presence or abundance of a nucleic acid at a specific location within a tissue section by using an array of capture agents that include both a binding sequence and a location-specific coding tag. The dependent claims serve to specify various technical parameters and process variations, such as the types of nucleic acids and tissue sections used, the physical structure of the array features, specific biochemical steps like amplification and sequencing, and the density of capture agents and features on the array.

Key Claim Terms New

Definitions of key terms used in the patent claims.

Term (Source)Support for SpecificationInterpretation
Array
(Claim 1)
The assay system comprises an assay where encoded probes are provided to a biological sample in defined spatial patterns. The assay system can utilize an encoding scheme that comprises a 2-dimensional grid format based on the discrete positioning of the binding agents in the substrate surfaces. In certain aspects, the binding agents are immobilized directly to the substrate surface, and the location is known or determined prior to use.A substrate surface containing a plurality of features at discrete, known positions used to facilitate the spatial encoding of biological targets.
Capture agent
(Claim 1)
The assay system utilizes one or more binding agents that specifically bind to the biological molecule of interest and unique coding identifiers associated with specific binding agents. In specific aspects, the binding agents are nucleic acids immobilized directly or indirectly to the substrate surface. The encoding scheme allows one to determine the location of biological targets after the products are removed from the biological sample and pooled for analysis.A molecular construct used to identify and localize a target, comprising a first sequence for specific binding to a nucleic acid and a second sequence containing a coding tag that identifies the agent's spatial position on an array.
Coding tag
(Claim 1)
Each encoded probe comprises a probe region that may interact with the biological targets and a coding tag that identifies a location of the site to which the encoded probe was delivered. The encoding scheme used in these assay systems allows one to determine the location of biological targets or activity in the biological samples. Decoding of the encoding scheme can be performed by, e.g., next-generation sequencing.A nucleic acid sequence within a capture agent that serves as a spatial identifier, where the specific sequence corresponds to a known physical location on the array.
Tissue section
(Claim 1)
The assay systems detect the presence or absence and relative amount of a biological target as well as the location of the biological target in a biological sample, e.g., a tissue section. The assay may be designed to preserve the relative position of cells in a tissue. The technology allows for measurement of numerous biological targets in a meaningful spatial environment.A biological sample or structure, such as a thin slice of preserved tissue, disposed upon a support for spatial analysis of its biological molecules.

Litigation Cases New

US Latest litigation cases involving this patent.

Case NumberFiling DateTitle
1:23-cv-01375Dec 1, 202310X Genomics, Inc. V. Curio Bioscience, Inc.

Patent Family

Patent Family

File Wrapper

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents

US10662468

Application Number
US16660234A
Filing Date
Oct 22, 2019
Publication Date
May 26, 2020
External Links
Slate, USPTO , Google Patents